Financials

  • Market Capitalization 8.64 B
  • Employee 399
  • Founded 1993
  • CEO Michael S Weiss
  • Website www.tgtherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000FVZQY1
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
20.05
Fiyat/satışlar oranı
10.98

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
973
CRNX
Crinetics Pharmaceuticals, Inc. - Common Stock
84.95 USD0.00%+0.12%+1.53%+106.69%9.01 B USD
986
ABVX
Abivax SA - American Depositary Shares
112.31 USD-1.20%-4.69%-6.72%+36.33%8.82 B USD
1015
APGE
Apogee Therapeutics, Inc. - Common Stock
135.08 USD0.00%+0.09%+0.72%+152.06%8.40 B USD
1025
IBRX
ImmunityBio, Inc. - Common Stock
7.82 USD-0.64%-5.10%+8.91%+227.20%8.29 B USD

Haberler